Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.39 USD | 0.00% | -17.63% | -56.37% |
Financials (USD)
Sales 2024 * | 440M | Sales 2025 * | 464M | Capitalization | 345M |
---|---|---|---|---|---|
Net income 2024 * | -84M | Net income 2025 * | -77M | EV / Sales 2024 * | 0.57 x |
Net cash position 2024 * | 92.26M | Net cash position 2025 * | 81.38M | EV / Sales 2025 * | 0.57 x |
P/E ratio 2024 * |
-4.06
x | P/E ratio 2025 * |
-4.48
x | Employees | 1,215 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.56% |
Latest transcript on Nevro Corp.
1 week | -17.63% | ||
Current month | -11.25% | ||
1 month | -17.05% | ||
3 months | -39.96% | ||
6 months | -42.39% | ||
Current year | -56.37% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Thornal
CEO | Chief Executive Officer | 50 | 23-04-23 |
D. Grossman
CHM | Chairman | 63 | 19-03-18 |
Roderick MacLeod
DFI | Director of Finance/CFO | 57 | 20-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael DeMane
BRD | Director/Board Member | 67 | 11-03-16 |
Karen Prange
BRD | Director/Board Member | 60 | 19-12-16 |
D. Grossman
CHM | Chairman | 63 | 19-03-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 9.39 | 0.00% | 431,529 |
24-05-23 | 9.39 | -4.28% | 631,098 |
24-05-22 | 9.81 | -1.51% | 630,633 |
24-05-21 | 9.96 | -5.32% | 473,551 |
Delayed Quote Nyse, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.37% | 345M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+2.98% | 41.3B | |
+21.98% | 31.6B | |
+16.49% | 25.03B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- NVRO Stock